IL6 and breast carcinoma: In accordance with this finding, previous clinical studies had shown that the elevated serum concentrations of IL-6 and IL-8 of breast cancer patients correlate with the stage of the disease, the recurrence, and are indicators of poor prognosis [46,47,48].